120 related articles for article (PubMed ID: 6429399)
1. Combined cytotoxic and endocrine therapy for human breast carcinoma (Br-10) serially transplanted into nude mice.
Kubota T; Kubouchi K; Koh J; Asanuma F; Enomoto K; Ishibiki K; Abe O
Jpn J Surg; 1984 Jan; 14(1):78-84. PubMed ID: 6429399
[TBL] [Abstract][Full Text] [Related]
2. [Experimental chemo- and chemoendocrine therapy of human breast carcinomas serially transplanted into nude mice].
Koh J
Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):91-102. PubMed ID: 3129645
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors.
Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
Cancer; 1988 Jun; 61(11):2168-75. PubMed ID: 3130175
[TBL] [Abstract][Full Text] [Related]
4. Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status.
Nomura Y; Shirouzu M; Takayama T
Breast Cancer Res Treat; 1998 May; 49(1):51-60. PubMed ID: 9694611
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of antitumor activity of mitomycin C by estradiol: studies of human breast carcinoma xenografts serially transplanted into nude mice.
Oka S; Kubota T; Takeuchi T; Kitajima M
J Surg Oncol; 1996 Apr; 61(4):256-61. PubMed ID: 8627994
[TBL] [Abstract][Full Text] [Related]
6. Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer.
Sugimachi K; Maehara Y; Akazawa K; Nomura Y; Eida K; Ogawa M; Konaga E; Tanaka N; Toge T; Dohi K; Noda S; Maeda M; Monden Y
Breast Cancer Res Treat; 1999 Jul; 56(2):113-24. PubMed ID: 10573104
[TBL] [Abstract][Full Text] [Related]
7. [Experimental combined chemo- and endocrine therapy with UFT and tamoxifen in human breast carcinoma xenografts serially transplanted into nude mice].
Kubota T; Josui K; Ishibiki K; Abe O; Yamada Y; Asanuma F; Kawamura E; Koh J; Shiina E
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2767-73. PubMed ID: 2074386
[TBL] [Abstract][Full Text] [Related]
8. Changes in the hormone receptors of human breast carcinoma xenografts in nude mice by treatment with cytotoxic agents.
Koh J; Shiina E; Hosoda Y; Hashimoto M; Yamamoto O; Sakai S; Kubota T; Enomoto K; Abe O
Jpn J Surg; 1990 Jan; 20(1):89-96. PubMed ID: 2106048
[TBL] [Abstract][Full Text] [Related]
9. [Experimental and clinical study on endocrine therapy of breast carcinoma, with special reference to the nuclear estrogen receptor].
Kubouchi K
Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1405-17. PubMed ID: 6521721
[TBL] [Abstract][Full Text] [Related]
10. [Enhancement of antitumor activity of mitomycin C against human breast carcinoma xenografts by pretreatment with KM 2210].
Yamamoto T; Kubota T; Oka S; Josui K; Fujita S; Arisawa Y; Suto A; Inoue S; Kuzuoka M; Ishibiki K
Gan To Kagaku Ryoho; 1990 Jan; 17(1):109-14. PubMed ID: 2105084
[TBL] [Abstract][Full Text] [Related]
11. [Experimental chemoendocrine therapy of human breast carcinoma xenograft serially transplanted into nude mice].
Watanabe O
Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):263-70. PubMed ID: 7910941
[TBL] [Abstract][Full Text] [Related]
12. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
[TBL] [Abstract][Full Text] [Related]
13. [Combination cancer chemotherapy of human gastric and colon carcinomas in nude mice--sequential cancer chemotherapy involving mitomycin C and tegafur].
Kubota T; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):938-44. PubMed ID: 3083789
[TBL] [Abstract][Full Text] [Related]
14. [Experimental combination chemo-radiotherapy on human breast carcinoma (MX-1) transplanted into nude mice].
Tsuyuki K
Nihon Geka Gakkai Zasshi; 1984 May; 85(5):421-32. PubMed ID: 6431259
[TBL] [Abstract][Full Text] [Related]
15. [Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach].
Kitaoka H
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2453-60. PubMed ID: 6418074
[TBL] [Abstract][Full Text] [Related]
16. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
Waseda N; Kato Y; Imura H; Kurata M
Cancer Res; 1981 May; 41(5):1984-8. PubMed ID: 7214366
[TBL] [Abstract][Full Text] [Related]
18. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
[TBL] [Abstract][Full Text] [Related]
19. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
20. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
